Akt activation has been shown to correlate with a poorer prognostic outcome in NB, and is associated with other markers of aggressive disease, including NMYC amplification, advanced disease stage and unfavorable histology (Opel et al., 2007). Here, AKT1 is linked to neuroblastoma.